Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors

scientific article published on 17 March 2020

Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCICS/PKAA017
P932PMC publication ID7236780
P698PubMed publication ID32455335

P50authorChunkit FungQ91807094
Paul C DinhQ95822328
Darren R FeldmanQ56588360
Michael T MilanoQ90387310
Sophie D FossaQ91444278
Lois B. TravisQ91794501
P2093author name stringHongmei Yang
Patrick O Monahan
Mohammad Abu Zaid
P2860cites workSecond malignant neoplasms and cardiovascular disease following radiotherapyQ26864522
Cancer treatment and survivorship statistics, 2012Q27020961
Projected cancer risks from computed tomographic scans performed in the United States in 2007Q28267626
Comparison of SEER Treatment Data With Medicare ClaimsQ30779910
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 dataQ31122446
Therapy-related malignancies following treatment of germ cell cancerQ33793905
Testicular cancer survivorship: research strategies and recommendationsQ34039684
Increasing incidence of testicular cancer worldwide: a reviewQ34534348
Increased stomach cancer risk following radiotherapy for testicular cancerQ35677701
Outcomes in stage I testicular seminoma: a population-based study of 9193 patientsQ35780174
Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasionQ35832143
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendationsQ36359653
Secondary gastrointestinal cancer in childhood cancer survivors: a cohort studyQ36560166
Mortality and incidence of second cancers following treatment for testicular cancerQ36609806
A study of soft tissue sarcomas after childhood cancer in BritainQ36611058
Renal carcinoma after childhood cancer: a report from the childhood cancer survivor study.Q36953566
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based studyQ37227682
Second cancer risk and mortality in men treated with radiotherapy for stage I seminomaQ37459549
Second malignant neoplasms: assessment and strategies for risk reductionQ38046164
Testicular cancer--discoveries and updatesQ38269543
Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survivalQ38656848
Increased pancreatic cancer risk following radiotherapy for testicular cancerQ39419020
Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerQ39452307
Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemiaQ39962944
Surveillance and Radiation Therapy for Stage I Seminoma--Have We Learned From the Evidence?Q40174962
Second Malignant Neoplasms and Cause of Death in Patients With Germ Cell Cancer: A Danish Nationwide Cohort StudyQ40551817
Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapyQ42384332
Cancer risk prediction models: a workshop on development, evaluation, and applicationQ44065523
Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminomaQ44968874
Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillanceQ45001991
Second cancers after testicular cancer diagnosed after 1980 in SwedenQ46412460
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AHQ46610975
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).Q52858240
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term SurvivorsQ58411051
Treatment-Associated Leukemia Following Testicular CancerQ58411442
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working PartyQ67558802
Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancerQ73100643
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working GroupQ73181376
Surveillance in stage I testicular cancerQ73404456
Testicular germ-cell cancerQ73520726
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumorsQ73944612
Radiotherapy for stage II testicular seminomaQ74613874
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214)Q83333663
Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum EraQ89496327
Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern EraQ90664127
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjecttesticular cancerQ324464
P304page(s)pkaa017
P577publication date2020-03-17
P1433published inJNCI Cancer SpectrumQ68836165
P1476titleSolid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24 900 Survivors
P478volume4